Blueberry Consumption for Vascular Diseases

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
NewBridge on the Charles, Dedham, MA
Vascular Diseases+4 More
Blueberry Consumption - Behavioral
Eligibility
65+
All Sexes
What conditions do you have?
Select

Study Summary

This randomized, parallel-design trial will evaluate specific clinical and physiological effects of whole blueberries in adults 70 years of age or older at a congregate-living facility.

Eligible Conditions

  • Vascular Diseases
  • Orthostatic Hypotension
  • Blood Pressures

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

4 Primary · 19 Secondary · Reporting Duration: 12 weeks after randomization

12 weeks after randomization
Albumin-to-Creatinine Ratio
Ambulatory Blood Pressure Monitoring
C-Reactive Protein (CRP)
C-terminal telopeptide of type 1 collagen
Cardiac Ectopy
Cognition
Derived Low Density Lipoprotein Cholesterol
Estimated Glomerular Filtration Rate (eGFR)
Fasting Glucose
Fasting Insulin
Free Fatty Acids
Fructosamine
Grip Strength
High Density Lipoprotein Cholesterol
Immune System Diversity
Incontinence
Liver Enzymes
Lower Extremity Functioning
Sleep
T-Cell Receptor Portfolio
Total Cholesterol
Total and Direct Bilirubin
Triglycerides
Troponin T (HS)
White Blood Cell Count
12-weeks after randomization
Orthostatic Hypotension
Week 12
Falls
Number of Self-Reported Falls

Trial Safety

Safety Progress

1 of 3

Trial Design

2 Treatment Groups

Dried Date Consumption
1 of 2
Blueberry Consumption
1 of 2
Active Control
Experimental Treatment

70 Total Participants · 2 Treatment Groups

Primary Treatment: Blueberry Consumption · No Placebo Group · N/A

Blueberry Consumption
Behavioral
Experimental Group · 1 Intervention: Blueberry Consumption · Intervention Types: Behavioral
Dried Date Consumption
Behavioral
ActiveComparator Group · 1 Intervention: Dried Date Consumption · Intervention Types: Behavioral

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: 12 weeks after randomization
Closest Location: NewBridge on the Charles · Dedham, MA
Photo of massachusetts 1Photo of massachusetts 2Photo of massachusetts 3
N/AFirst Recorded Clinical Trial
1 TrialsResearching Vascular Diseases
0 CompletedClinical Trials

Who is running the clinical trial?

U.S. Highbush Blueberry CouncilOTHER
15 Previous Clinical Trials
859 Total Patients Enrolled
Beth Israel Deaconess Medical CenterLead Sponsor
767 Previous Clinical Trials
849,047 Total Patients Enrolled
3 Trials studying Vascular Diseases
1,018 Patients Enrolled for Vascular Diseases
Kenneth J Mukamal, MD, MPHPrincipal InvestigatorBeth Israel Deaconess Medical Center

Eligibility Criteria

Age 65+ · All Participants · 3 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.